Clinical Trial Update: Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial using 18F-FAPI PET imaging to detect metastatic disease in patients with gastric or esophageal cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• 18F-FAPI PET tracer (18F-labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: SOFIE | Conditions: Esophageal Cancer, Gastric Cancer (GC) | Phase 3 | Status: RECRUITING